Payments to Acquire Property, Plant, and Equipment of Crinetics Pharmaceuticals, Inc. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Crinetics Pharmaceuticals, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Crinetics Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $1,239,000, a 7% decline year-over-year.
  • Crinetics Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $5,762,000, a 50% increase from 2024.
  • Crinetics Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $3,844,000, a 18% decline from 2023.
  • Crinetics Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $4,688,000, a 183% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Crinetics Pharmaceuticals, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $5,762,000 +$1,918,000 +50% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $3,844,000 -$844,000 -18% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $4,688,000 +$3,032,000 +183% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $1,656,000 +$1,220,000 +280% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $436,000 +$250,000 +134% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $186,000 -$306,000 -62% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $492,000 -$567,000 -54% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2022 2021 FY
2018 $1,059,000 +$755,000 +248% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2021 2020 FY
2017 $304,000 +$114,000 +60% 01 Jan 2017 31 Dec 2017 10-K 09 Mar 2020 2019 FY
2016 $190,000 01 Jan 2016 31 Dec 2016 10-K 13 Mar 2019 2018 FY

Crinetics Pharmaceuticals, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,239,000 -$93,000 -7% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $1,332,000 +$1,316,000 +8225% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $16,000 -$71,000 -82% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $87,000 -$29,000 -25% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $116,000 +$56,000 +93% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $60,000 -$348,000 -85% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $408,000 +$351,000 +616% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $57,000 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.